 According to recent reports, the global electroceuticalsbioelectric medicine market is currently worth 16.8 billion and is projected to reach 21.5 billion by 2026, at a compound annual growth rate CAGR of 5.0 BioSig Technologies, Inc. NASDAQ: BSGM, a medical technology company, unlocks the future of bioelectronic medicine with its PURE EP SystemTM. The company recently increased its procedural volume targets to 15,000 due to accelerated technology usage, after delivering 425 procedures at the end of 2020. 